Cargando…
Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serod...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263699/ https://www.ncbi.nlm.nih.gov/pubmed/34234232 http://dx.doi.org/10.1038/s41598-021-93443-x |
_version_ | 1783719426840854528 |
---|---|
author | Wu, Haisheng Yu, Qiuyan Ma, Liping Zhang, Lin Chen, Yuliang Guo, Pi Xu, Peng |
author_facet | Wu, Haisheng Yu, Qiuyan Ma, Liping Zhang, Lin Chen, Yuliang Guo, Pi Xu, Peng |
author_sort | Wu, Haisheng |
collection | PubMed |
description | Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serodiscordant couples in the China context. A deterministic model of HIV evolution and transmission within a cohort of serodiscordant couples was parameterized using the real-world database of Zhoukou city and published literature. We evaluated the mid-ART (a historical strategy, initiating ART with CD4 < 500 cells/mm(3)), early-ART (the current strategy, offering ART regardless of CD4 cell counts) and a hypothetical strategy (early-ART combined short-term daily PrEP) versus the late-ART (the baseline strategy, initiating ART with CD4 < 350 cells/mm(3)) offered by 2008 national guidelines. We estimated the incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICUR) from a societal perspective, derived by clinical benefits and HIV-caused life quality respectively, and portrayed their changes over a 0–30 year’s timeframe. The model projections indicated that the antiretroviral-based interventions were more likely to obtain clinical benefits but difficult to improve quality of life, and cumulative ICER and ICUR were generally decreasing without achieving cost-saving. Scale-up access to ART for the HIV-positive among serodiscordant couples was easily fallen within the range of paying for incremental life-years and quality adjusted life years by the societal willingness. The hypothetical strategy had the potential to prevent most seroconversion events within marriages but required enormous upfront costs, thus it took a long time to reach established thresholds. The current strategy of early-ART is the most cost-effective. Clarifying the obstacles of high cost of PrEP and improving life quality for HIV-serodiscordant couples have emerged as an urgent requisition. |
format | Online Article Text |
id | pubmed-8263699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82636992021-07-09 Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples Wu, Haisheng Yu, Qiuyan Ma, Liping Zhang, Lin Chen, Yuliang Guo, Pi Xu, Peng Sci Rep Article Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serodiscordant couples in the China context. A deterministic model of HIV evolution and transmission within a cohort of serodiscordant couples was parameterized using the real-world database of Zhoukou city and published literature. We evaluated the mid-ART (a historical strategy, initiating ART with CD4 < 500 cells/mm(3)), early-ART (the current strategy, offering ART regardless of CD4 cell counts) and a hypothetical strategy (early-ART combined short-term daily PrEP) versus the late-ART (the baseline strategy, initiating ART with CD4 < 350 cells/mm(3)) offered by 2008 national guidelines. We estimated the incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICUR) from a societal perspective, derived by clinical benefits and HIV-caused life quality respectively, and portrayed their changes over a 0–30 year’s timeframe. The model projections indicated that the antiretroviral-based interventions were more likely to obtain clinical benefits but difficult to improve quality of life, and cumulative ICER and ICUR were generally decreasing without achieving cost-saving. Scale-up access to ART for the HIV-positive among serodiscordant couples was easily fallen within the range of paying for incremental life-years and quality adjusted life years by the societal willingness. The hypothetical strategy had the potential to prevent most seroconversion events within marriages but required enormous upfront costs, thus it took a long time to reach established thresholds. The current strategy of early-ART is the most cost-effective. Clarifying the obstacles of high cost of PrEP and improving life quality for HIV-serodiscordant couples have emerged as an urgent requisition. Nature Publishing Group UK 2021-07-07 /pmc/articles/PMC8263699/ /pubmed/34234232 http://dx.doi.org/10.1038/s41598-021-93443-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wu, Haisheng Yu, Qiuyan Ma, Liping Zhang, Lin Chen, Yuliang Guo, Pi Xu, Peng Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples |
title | Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples |
title_full | Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples |
title_fullStr | Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples |
title_full_unstemmed | Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples |
title_short | Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples |
title_sort | health economics modeling of antiretroviral interventions amongst hiv serodiscordant couples |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263699/ https://www.ncbi.nlm.nih.gov/pubmed/34234232 http://dx.doi.org/10.1038/s41598-021-93443-x |
work_keys_str_mv | AT wuhaisheng healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples AT yuqiuyan healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples AT maliping healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples AT zhanglin healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples AT chenyuliang healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples AT guopi healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples AT xupeng healtheconomicsmodelingofantiretroviralinterventionsamongsthivserodiscordantcouples |